{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:07:51Z","timestamp":1772118471821,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Heart J Cardiovasc Pharmacother"],"DOI":"10.1093\/ehjcvp\/pvw035","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T07:07:09Z","timestamp":1477638429000},"page":"pvw035","source":"Crossref","is-referenced-by-count":11,"title":["Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial"],"prefix":"10.1093","author":[{"given":"Otto","family":"Hartman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri T.","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari K.","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Sinisalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"2016122617103653000_pvw035v2.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1216063"},{"key":"2016122617103653000_pvw035v2.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.15.9.1512"},{"key":"2016122617103653000_pvw035v2.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.5.1084"},{"key":"2016122617103653000_pvw035v2.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"2016122617103653000_pvw035v2.5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/pr.114.010090","article-title":"Toll-like receptors in the vascular system: sensing the dangers within","volume":"68","author":"Goulopoulou","year":"2016","journal-title":"Pharmacol Rev"},{"key":"2016122617103653000_pvw035v2.6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2005"},{"key":"2016122617103653000_pvw035v2.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938"},{"key":"2016122617103653000_pvw035v2.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011765"},{"key":"2016122617103653000_pvw035v2.9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"2016122617103653000_pvw035v2.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.002"},{"key":"2016122617103653000_pvw035v2.11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0110"},{"key":"2016122617103653000_pvw035v2.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"2016122617103653000_pvw035v2.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3609"},{"key":"2016122617103653000_pvw035v2.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11061"},{"key":"2016122617103653000_pvw035v2.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282836"},{"key":"2016122617103653000_pvw035v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.03.018"},{"key":"2016122617103653000_pvw035v2.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.06.012"},{"key":"2016122617103653000_pvw035v2.18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000702"},{"key":"2016122617103653000_pvw035v2.19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"key":"2016122617103653000_pvw035v2.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei282"},{"key":"2016122617103653000_pvw035v2.21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1534"},{"key":"2016122617103653000_pvw035v2.22","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"2016122617103653000_pvw035v2.23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309356455"},{"key":"2016122617103653000_pvw035v2.24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.matbio.2015.01.015","article-title":"Metalloproteinases promote plaque rupture and myocardial infarction: a persuasive concept waiting for clinical translation","volume":"44\u201346","author":"Newby","year":"2015","journal-title":"Matrix Biol"},{"key":"2016122617103653000_pvw035v2.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2012.02886.x"},{"key":"2016122617103653000_pvw035v2.26","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90345-E"},{"key":"2016122617103653000_pvw035v2.27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.20393","article-title":"Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients","volume":"63","author":"Morris","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2016122617103653000_pvw035v2.28","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22341"},{"key":"2016122617103653000_pvw035v2.29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90151-1"},{"key":"2016122617103653000_pvw035v2.30","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e318214b6b5"},{"key":"2016122617103653000_pvw035v2.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.878"},{"key":"2016122617103653000_pvw035v2.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.2.187"},{"key":"2016122617103653000_pvw035v2.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.27703"},{"key":"2016122617103653000_pvw035v2.34","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","article-title":"Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial","volume":"58","author":"Wasko","year":"2015","journal-title":"Diabetologia"},{"key":"2016122617103653000_pvw035v2.35","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-9-678"},{"key":"2016122617103653000_pvw035v2.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(01)00325-4"},{"key":"2016122617103653000_pvw035v2.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0141-y"},{"key":"2016122617103653000_pvw035v2.38","doi-asserted-by":"publisher","DOI":"10.1177\/1074248414546324"},{"key":"2016122617103653000_pvw035v2.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.12.4380"},{"key":"2016122617103653000_pvw035v2.40","doi-asserted-by":"crossref","first-page":"e0139226.","DOI":"10.1371\/journal.pone.0139226","article-title":"Impact of hydroxychloroquine on atherosclerosis and vascular stiffness in the presence of chronic kidney disease","volume":"10","author":"Shukla","year":"2015","journal-title":"PLoS One"},{"key":"2016122617103653000_pvw035v2.41","doi-asserted-by":"publisher","DOI":"10.1002\/art.27289"},{"key":"2016122617103653000_pvw035v2.42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002867"},{"key":"2016122617103653000_pvw035v2.43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs184"},{"key":"2016122617103653000_pvw035v2.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.018"},{"key":"2016122617103653000_pvw035v2.45","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr090"},{"key":"2016122617103653000_pvw035v2.46","unstructured":"Lenth RV , Java Applets for Power and Sample Size (Computer software). http:\/\/www.stat.uiowa.edu\/\u223crlenth\/Power (29 February 2016)."},{"key":"2016122617103653000_pvw035v2.47","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007380408729"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/3\/2\/92\/11007810\/pvw035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T23:57:11Z","timestamp":1568505431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-lookup\/doi\/10.1093\/ehjcvp\/pvw035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":47,"alternative-id":["10.1093\/ehjcvp\/pvw035"],"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvw035","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}